Breast Cancer Diagnostics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Breast Cancer Diagnostics Market to 2027 - Global Analysis and Forecasts by Screening Type (Laboratory Tests, Biopsy, Imaging, and Other Screening Types), Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), and Other Technologies), and Geography

Report Code: TIPRE00003015 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Breast cancer is the uncontrollable growth of tumour cells in the breasts. Generally, the cancer forms in either the lobules or the ducts of the breast. There are two types of breast cancers, invasive breast cancer and non-invasive breast cancer. During recent years, there has been an increase in the cases of breast cancer in women. Recently, breast cancer is also being detected in men. The American Cancer Society estimated that in 2015, more than 2,000 men would be diagnosed, and more than 400 men would die from the disease.

Increasing prevalence of breast cancer along with advanced technology for its diagnosis is expected to fuel the growth of the breast cancer diagnosis market during the forecast period. Moreover, the introduction of new and better products by manufacturers is anticipated to offer growth opportunities to the companies in the market.

The "Global Breast Cancer Diagnosis Market Analysis to 2027" is a specialized and in-depth study of the healthcare IT industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by screening type, technology and geography. The global market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading breast cancer diagnosis market players and offers key trends and opportunities in the market.

The global breast cancer diagnosis market is segmented on the basis of screening type and technology. Based on screening type, the market is segmented as, laboratory tests, biopsy, imaging, and other screening types. On the basis of technology, the breast cancer diagnosis market is classified as, fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), immunohistochemical (IHC), and other technologies.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global breast cancer diagnosis market based on screening type and technology. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The breast cancer diagnosis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the breast cancer diagnosis market in the coming years, owing to rising prevalence of breast cancer cases in the region during the recent years. Asia Pacific is expected to witness significant growth in the market during the forecast period, due to rising investment of foreign players in developing economies such as, China and India.

The report analyzes factors affecting breast cancer diagnosis market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the breast cancer diagnosis market in these regions.

The report also includes the profiles of key breast cancer diagnosis companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the breast cancer diagnosis market include, Abbott, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, GENERAL ELECTRIC COMPANY, Hologic, Inc., Koninklijke Philips N.V., Micrima Limited, Provista Diagnostics, Inc., Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc. among others.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Breast Cancer Diagnostics Market- By Screening Type
1.3.2. Breast Cancer Diagnostics Market- By Technology
1.3.3. Breast Cancer Diagnostics Market- By Region
1.3.3.1. By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BREAST CANCER DIAGNOSTICS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. BREAST CANCER DIAGNOSTICS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BREAST CANCER DIAGNOSTICS MARKET- GLOBAL ANALYSIS
6.1. BREAST CANCER DIAGNOSTICS MARKET - GLOBAL MARKET OVERVIEW
6.2. BREAST CANCER DIAGNOSTICS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. BREAST CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - SCREENING TYPE
7.1. OVERVIEW
7.2. SCREENING TYPE MARKET FORECASTS AND ANALYSIS
7.3. LABORATORY TESTS MARKET
7.3.1. Overview
7.3.2. Laboratory Tests Market Forecast and Analysis (US$ Mn)
7.4. BIOPSY MARKET
7.4.1. Overview
7.4.2. Biopsy Market Forecast and Analysis (US$ Mn)
7.5. IMAGING MARKET
7.5.1. Overview
7.5.2. Imaging Market Forecast and Analysis (US$ Mn)
7.6. OTHER SCREENING TYPES MARKET
7.6.1. Overview
7.6.2. Other Screening Types Market Forecast and Analysis (US$ Mn)

8. BREAST CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET
8.3.1. Overview
8.3.2. Fluorescent In Situ Hybridization (FISH) Market Forecast and Analysis (US$ Mn)
8.4. COMPARATIVE GENOMIC HYBRIDIZATION (CGH) MARKET
8.4.1. Overview
8.4.2. Comparative Genomic Hybridization (CGH) Market Forecast and Analysis (US$ Mn)
8.5. IMMUNOHISTOCHEMICAL (IHC) MARKET
8.5.1. Overview
8.5.2. Immunohistochemical (IHC) Market Forecast and Analysis (US$ Mn)
8.6. OTHER TECHNOLOGIES MARKET
8.6.1. Overview
8.6.2. Other Technologies Market Forecast and Analysis (US$ Mn)

9. BREAST CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA BREAST CANCER DIAGNOSTICS MARKET
9.1.1. North America Breast Cancer Diagnostics Market Forecasts and Analysis (US$ Mn)
9.1.2. North America Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.1.3. North America Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.1.4. North America Breast Cancer Diagnostics Market Forecasts and Analysis - By Country
9.1.5. US Market Overview
9.1.5.1. US Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.1.5.2. US Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.1.6. Canada Market Overview
9.1.6.1. Canada Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.1.6.2. Canada Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.1.7. Mexico Market Overview
9.1.7.1. Mexico Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.1.7.2. Mexico Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.2. EUROPE BREAST CANCER DIAGNOSTICS MARKET
9.2.1. Europe Breast Cancer Diagnostics Market Forecasts and Analysis (US$ Mn)
9.2.2. Europe Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.2.3. Europe Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.2.4. Europe Breast Cancer Diagnostics Market Forecasts and Analysis - By Country
9.2.5. UK Market Overview
9.2.5.1. UK Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.2.5.2. UK Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.2.6. Germany Market Overview
9.2.6.1. Germany Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.2.6.2. Germany Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.2.7. France Market Overview
9.2.7.1. France Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.2.7.2. France Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.3. ASIA PACIFIC BREAST CANCER DIAGNOSTICS MARKET
9.3.1. Asia Pacific Breast Cancer Diagnostics Market Forecasts and Analysis (US$ Mn)
9.3.2. Asia Pacific Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.3.3. Asia Pacific Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.3.4. Asia Pacific Breast Cancer Diagnostics Market Forecasts and Analysis - By Country
9.3.5. Japan Market Overview
9.3.5.1. Japan Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.3.5.2. Japan Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.3.6. India Market Overview
9.3.6.1. India Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.3.6.2. India Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.3.7. China Market Overview
9.3.7.1. China Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.3.7.2. China Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.4. MIDDLE EAST & AFRICA (MEA) BREAST CANCER DIAGNOSTICS MARKET
9.4.1. Middle East & Africa (MEA) Breast Cancer Diagnostics Market Forecasts and Analysis (US$ Mn)
9.4.2. Middle East & Africa (MEA) Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.4.3. Middle East & Africa (MEA) Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.4.4. Middle East & Africa (MEA) Breast Cancer Diagnostics Market Forecasts and Analysis - By Country
9.4.5. South Africa Market Overview
9.4.5.1. South Africa Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.4.5.2. South Africa Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.4.6. Saudi Arabia Market Overview
9.4.6.1. Saudi Arabia Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.4.6.2. Saudi Arabia Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.4.7. UAE Market Overview
9.4.7.1. UAE Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.4.7.2. UAE Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.5. SOUTH AND CENTRAL AMERICA BREAST CANCER DIAGNOSTICS MARKET
9.5.1. South and Central America Breast Cancer Diagnostics Market Forecasts and Analysis (US$ Mn)
9.5.2. South and Central America Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.5.3. South and Central America Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
9.5.4. South and Central America Breast Cancer Diagnostics Market Forecasts and Analysis - By Country
9.5.5. Brazil Market Overview
9.5.5.1. Brazil Breast Cancer Diagnostics Market Forecasts and Analysis - By Screening Type (US$ Mn)
9.5.5.2. Brazil Breast Cancer Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)

10. INDUSTRY LANDSCAPE
10.1. ORGANIC GROWTH STRATEGIES
10.1.1. New Product Launches
10.1.2. Marketing & Promotional Activities
10.2. INORGANIC GROWTH STRATEGIES
10.2.1. Partnerships, Collaborations, and Joint Ventures
10.2.2. Mergers & Acquisitions

11. BREAST CANCER DIAGNOSTICS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Financial Overview
11.1.4. Product/Service Portfolio
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. F. HOFFMANN-LA ROCHE LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Financial Overview
11.2.4. Product/Service Portfolio
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. FUJIFILM HOLDINGS CORPORATION
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Financial Overview
11.3.4. Product/Service Portfolio
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GENERAL ELECTRIC COMPANY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Financial Overview
11.4.4. Product/Service Portfolio
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. HOLOGIC, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Financial Overview
11.5.4. Product/Service Portfolio
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. KONINKLIJKE PHILIPS N.V.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Financial Overview
11.6.4. Product/Service Portfolio
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MICRIMA LIMITED
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Financial Overview
11.7.4. Product/Service Portfolio
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PROVISTA DIAGNOSTICS, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Financial Overview
11.8.4. Product/Service Portfolio
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SIEMENS HEALTHCARE GMBH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Financial Overview
11.9.4. Product/Service Portfolio
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. THERMO FISHER SCIENTIFIC INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Financial Overview
11.10.4. Product/Service Portfolio
11.10.5. SWOT Analysis
11.10.6. Key Developments
11.11. THERMO FISHER SCIENTIFIC INC.
11.11.1. Key Facts
11.11.2. Business Description
11.11.3. Financial Overview
11.11.4. Product/Service Portfolio
11.11.5. SWOT Analysis
11.11.6. Key Developments


12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. F. Hoffmann-La Roche Ltd
3. Fujifilm Holdings Corporation
4. GENERAL ELECTRIC COMPANY
5. Hologic, Inc.
6. Koninklijke Philips N.V.
7. Micrima Limited
8. Provista Diagnostics, Inc.
9. Siemens Healthcare GmbH
10. Thermo Fisher Scientific Inc.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book